Previous Article | Next Article 
Journal of Clinical Microbiology, July 2000, p. 2628-2632, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Quantitative Approach for the Serodiagnosis of
Canine Lyme Disease by the Immunoblot Procedure
Marta A.
Guerra,1,*
Edward D.
Walker,2 and
Uriel
Kitron1
Department of Veterinary Pathobiology,
Division of Epidemiology and Preventive Medicine, University of
Illinois College of Veterinary Medicine, Urbana, Illinois
61802,1 and Department of
Entomology, Michigan State University, East Lansing, Michigan
488242
Received 27 January 2000/Returned for modification 31 March
2000/Accepted 28 April 2000
 |
ABSTRACT |
Serum samples obtained from healthy, asymptomatic dogs in areas of
Wisconsin and northern Illinois where Lyme disease is endemic or
nonendemic were assayed for antibodies to Borrelia
burgdorferi by enzyme-linked immunosorbent assay (ELISA), and
positive results were confirmed by immunoblot assay. We found that
56.9% (562 of 1,077) of the samples were positive by ELISA and 82.0%
(461 of 562) were positive by immunoblotting. A logistic regression
model was developed to distinguish between nonvaccinated dogs naturally infected with B. burgdorferi from areas where the disease
is endemic and dogs from areas where the disease is nonendemic that
were vaccinated against Lyme disease. Of the 18 protein bands analyzed, 8 were found to be significantly different (P < 0.05)
between the two groups. p93, p34, p31, and p28 occurred with increased frequency in vaccinated dogs, while p58, p37, p35, and p30 occurred more frequently in naturally infected dogs. The logistic regression equation obtained was used to determine the probability of natural infection among vaccinated dogs residing in areas where the disease is
endemic. Of 125 samples, 87.2% had a very low probability of natural
infection and only 2.4% were highly likely to be infected. Logistic
regression is a useful method for distinguishing between vaccinated and
naturally infected dogs and predicting the serological status of
vaccinated dogs from areas where Lyme disease is endemic.
 |
INTRODUCTION |
Since Borrelia
burgdorferi was found to be the causative agent of Lyme disease,
various methods have been employed for the determination of antibodies
to the spirochete in humans and in domestic and wild animals. The
enzyme-linked immunosorbent assay (ELISA) and indirect
fluorescent-antibody assay (IFA) have been used to screen serum, and
immunoblotting techniques have been used to confirm positive results
(1, 5, 10, 15, 21, 22, 31). Various studies have determined
the type and number of bands that must be present for a sample to be
considered positive (5, 17, 24, 33) and to distinguish
between the early and late stages of Lyme disease in humans
(32). Band patterns may differ according to the duration of
infection and the type of B. burgdorferi strain affecting an
individual. In addition, antigens for serologic analysis are prepared
from cultured spirochetes, which may express different proteins than
spirochetes transmitted through natural infection. Therefore, the
number and type of bands present in positive immunoblots can be highly
variable and the diagnostic criteria used to identify positive
immunoblots are still controversial.
Immunoblotting has also been used to diagnose canine Lyme disease;
however, serologic diagnosis is complicated by the presence of
heterologous antibodies due to oral Treponema infection and Leptospira vaccination (19, 23, 26) and
vaccination with whole-cell Lyme disease bacterins (Fort Dodge
Laboratories, Fort Dodge, Iowa). In areas where Lyme disease is endemic
and the vaccine is used extensively, it is difficult to determine
whether a vaccinated dog exhibiting symptoms of Lyme disease was
infected prior to vaccination or whether the dog acquired a natural
infection despite vaccination. Jacobson et al. (12) reported
that vaccinated dogs developed strong antibody responses to OspA (p31)
and OspB (p34) and usually did not develop responses to p30, p28, and
p19. Wittenbrink et al. (31) documented the presence of six
major bands, p93, p75, p60, p41, p39, and p31, with vaccinated dogs
reacting to a smaller number of bands. In another canine study
(9), different immunoblot patterns were found among four
B. burgdorferi strains, especially in the 45- to 34-kDa and
26- to 15-kDa ranges. No definitive criteria have been established to
distinguish naturally infected, unvaccinated dogs from vaccinated dogs
that may also be harboring an active infection. Vaccines may induce the
presence of bands in immunoblots comparable in number and intensity to
those present in natural infection, thus obfuscating serologic test
results. Dogs are not routinely screened for antibodies to B. burgdorferi prior to vaccination in clinical settings; thus,
baseline information on the serologic status of dogs is generally not available.
Serologic analyses of dog sera by immunoblot assay are also important
for epidemiologic studies. Dogs are at higher risk for Lyme disease
than are humans in areas where it is endemic (16, 18) and
can act as sentinels to determine the regional risk of Lyme disease.
Serological analyses of dog sera from veterinary clinics have shown
positive correlations between the prevalence of antibodies to B. burgdorferi and the distribution of tick vectors. However, as with
serologic diagnosis in the clinical setting, vaccination may confound
the results of canine serosurveys conducted to aid in the preparation
of regional disease risk maps.
The primary purpose of this study was to compare the band patterns of
immunoblots of the sera of naturally infected dogs from areas where the
disease is endemic and vaccinated dogs from areas where the disease is
nonendemic in the upper midwestern United States. The bands that were
significantly different between these two groups were determined using
logistic regression analysis, and a final model was developed that best
distinguished between vaccinated and naturally infected dogs. This
model could then be used to compute the probability of natural
infection among vaccinated dogs from areas where the disease is endemic.
 |
MATERIALS AND METHODS |
Canine serum samples were obtained from 25 counties in Wisconsin
and 7 counties in northern Illinois to determine the distribution of
B. burgdorferi seropositivity. Participating clinics
submitted serum samples drawn from clinically normal canines for
routine diagnosis, such as for heartworm. The owner and veterinarian
together completed a questionnaire which included the following
information on each dog: age, sex, breed, residential address,
vaccination status, history of tick exposure, history of travel outside
the county, and history of symptoms consistent with Lyme disease. Each
clinic submitted 20 samples, with one to five clinics participating per
county. Only dogs that had not traveled outside of their county of
residence were included in the analysis presented here.
An ELISA similar to those described by Magnarelli et al.
(22) and Lindenmayer et al. (15) was used to
detect serum antibodies to B. burgdorferi as follows. Sera
were diluted 1:320 to reduce cross-reactivity with heterologous
antibodies (15, 19, 20, 26, 31). The antigen used was a
heat-killed, sonicated B. burgdorferi spirochete suspension
(Kirkegaard & Perry, Gaithersburg, Md.) diluted 1:100 in
carbonate-bicarbonate coating buffer (27.6 mM
Na2CO3, 19 mM NaHCO3, pH 9.6). Test
sera were diluted in blocking buffer (5% [wt/vol] blotting grade
dehydrated milk [Bio-Rad, Hercules, Calif.] in phosphate-buffered
saline). The detecting antibody was a peroxidase-labeled goat anti-dog
immunoglobulin G (IgG [heavy and light chains]; Kirkegaard & Perry)
diluted 1:8,000 in blocking buffer. The detecting substrate was
TMB-ELISA (tetramethyl benzidine; Life Technologies, Gaithersburg,
Md.). Reactions were stopped after incubation for 30 min with 2 N
H2SO4, and the optical density (OD) of wells
was read at 450 nm using an ELISA plate reader (Molecular Devices).
Samples were considered positive when the ODs were greater than or
equal to 3 standard deviations above the mean OD of negative controls.
The endpoint titers of positive sera were determined with twofold
serial dilutions. Positive control sera with high titers (
1:1,280)
were from a site in northern Michigan (30) or were obtained
courtesy of L. Magnarelli of the Connecticut Agricultural Experiment
Station (New Haven). Negative control canine sera were from dogs with
the following prerequisites: no history of vaccination for Lyme
disease, no history of tick bite, no suspected diagnosis of Lyme
disease, no periodontal disease, previously negative by IFA for
antibodies to B. burgdorferi (<1:160), and not resident of
an area where the disease is endemic (30). We used six
positive and six negative control sera on each microtiter plate, and
all sera were tested in duplicate.
Western blot analyses were performed on all samples positive by ELISA
using the Lyme Immunostrip IgG Assay kit (Immunetics, Inc., Cambridge,
Mass.). Aliquots (10 µl) of undiluted canine serum samples were added
to channels containing the test strips and 1 ml of dilution buffer.
Antigens on membranes of this kit were separated by the manufacturer
and include the following 18 bands: p93, p66, p60, p58, p45, p41, p39,
p37, p35, p34, p31, p30, p28, p23, p18, p17, p15, and p14.
Visualization of specific protein bands indicated the presence of serum
IgG antibodies against B. burgdorferi-derived antigens.
Samples were classified as positive or negative in accordance with the
criteria established by Immunetics, Inc. Positive samples had two or
more bands present in the p30 to p14 region, and negative samples had
less than two bands present in this region.
For this analysis, dogs were classified as naturally infected if they
had a positive immunoblot, had no history of vaccination, and resided
in the high- to moderate-risk Wisconsin counties of Chippewa, Eau
Claire, Washburn, Sawyer, Lincoln, Clark, and Marathon (2).
Dogs were classified as vaccinated if they had a positive immunoblot
result, if the owner and veterinarian reported vaccination with the
Lyme bacterin, and if they resided in the low- to no-risk counties of
DeKalb, Boone, LaSalle, and Green in Illinois and Green, Columbia,
Dodge, Fond du Lac, Outagamie, Rock, Walworth, Sauk, Oconto, Racine,
and Shawano in Wisconsin (2). The band frequencies of the
immunoblots from these canine samples were tabulated. A univariate
analysis was performed using the chi-square or Fisher exact test
(EPI-INFO, Atlanta, Ga.) to compare the frequencies of bands in sera
classified as vaccinated or naturally exposed. To determine whether any
band or group of bands was significantly associated with vaccination or
natural infection status, we performed a logistic regression (SPSS,
Chicago, Ill.) in which the dichotomous outcome variable was naturally
infected dogs from areas where Lyme disease is endemic (coded as one)
and vaccinated dogs from areas of low to no risk (coded as zero). The
independent variables were coded as the presence (code one) or absence
(code zero) of bands corresponding to the 18 antigens present on the
immunoblot strips. All independent variables were included in the
initial model. Variables (P < 0.10) were removed one
at a time from the regression model in a backward, stepwise fashion
until only those bands contributing significantly (P < 0.05) to the model remained. The final logistic regression
equation obtained was used to compute the probability of infection
among the vaccinated dogs from areas where the disease is endemic.
 |
RESULTS |
A total of 1,077 samples with accompanying completed
questionnaires was received from the participating veterinary clinics. Of these, 562 (52.2%) were positive by ELISA. Western blot analyses performed on these samples revealed 101 negatives and 461 positives. Of
the 461 immunoblot-positive samples, 89 were considered naturally infected and 234 were considered vaccinated by the previously stated
criteria. These samples were selected for the logistic regression
analysis. The remaining samples included those from 125 vaccinated dogs
residing in areas where the disease is endemic.
Figure 1 shows representative samples of
immunoblots obtained from this study. The immunoblots from the
vaccinated (lane 3) dog from an area where the disease is nonendemic
and the naturally infected (lane 2) dog from an area where the disease
is endemic differ mainly in the number of bands present within the
higher-molecular-weight region. The status of these dogs is fairly easy
to determine in accordance with previously established criteria.
However, the only difference between the immunoblots for infected (lane
2) and vaccinated (lane 4) dogs from areas where the disease is endemic was the presence of the p31 and p34 bands in samples from the vaccinated dog. This illustrates the difficulty in interpreting the
status of the immunoblot in lane 4.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 1.
Representative immunoblots from the Immunetics IgG test
kit. Lanes: 1, reference strip from Immunetics with bands identified;
2, naturally exposed dog from an area where the disease is endemic; 3, vaccinated dog from an area where the disease is nonendemic; 4, vaccinated dog from an area where the disease is endemic (all
significant bands are present); 5, negative dog; 6, positive control;
7, negative control. Abbreviations: Ref., reference; Inf., infected;
Vac., vaccinated; Neg., negative; Pos., positive; Cntrl., control.
|
|
The contingency table analysis of band frequencies of samples from
naturally infected and vaccinated dogs (Table
1) showed that all of the bands differed
significantly in frequency between these two groups (P < 0.05), except for bands p28, p21, and p17. However, there were no
bands that were uniquely present in one group. Using logistic
regression analysis, the final model (Table 2) indicated that eight bands were
significantly different between the vaccinated and naturally infected
groups. p58, p37, p35, and p30 were found to occur more frequently in
infected, nonvaccinated dogs, and p93, p34, p31, and p28 appeared more
often in vaccinated dogs. Differences in protein expression between
spirochetes that are transmitted to hosts via ticks and spirochetes
that are grown in culture may explain the differences in band
frequencies, as demonstrated in several studies. Schwan et al.
(28) reported that spirochetes in unfed ticks express OspA
(p31) on their surface, which is down-regulated as ticks begin to feed.
Fikrig et al. (6) showed that antibodies to p35 and p37 were
found in mice infected with B. burgdorferi via ticks but not
in mice infected with killed spirochetes.
The logistic regression model included the seven bands as significant
(P < 0.05) predictors of infection status and the
intercept term 2.85. The regression equation (10) assuming
z = log odds, was: z = 2.85
3.62(p93) + 2.10(p58) + 4.37(p37) + 2.70(p35)
2.90(p34)
6.84(p31) + 3.60(p30)
2.55(p28).
The Hosmer and Lemeshow (11) goodness-of-fit test indicated
no significant deviation of observed from expected values in the model
(
2 = 6.50, P = 0.48). The overall
fit of the model, as measured by the log-likelihood statistic
(G), was highly significant (
2 = 332.70, P < 0.0001). No significant interactions between bands were obtained from the model.
The probability that a vaccinated dog is also infected can be
calculated as follows. The value of z is estimated by
multiplying the coefficient of each independent variable by 1 if the
band is present in the immunoblot and by 0 if the band is absent. The z value is then entered into the following equation
(13): P(x) = 1/[1 + e
(Z)], where P(x) is the probability of
natural infection, ranging from 0 to 1. For example, in an immunoblot
having only the p31 and p34 bands (i.e., those bands most frequently
present in vaccinated, uninfected dogs), the probability that the dog
is also naturally infected is only 0.10%. In a sample containing all
of the bands except p31 and p34, the probability of natural infection
is very high (99.9%).
To test the predictive ability of the model, the immunoblot results for
the remaining 125 samples of vaccinated dogs from areas where the
disease is endemic were entered into the equation to determine the
probability of natural infection. Among the samples, 87.2% had a
probability of less than 10% of being naturally infected (Fig.
2). There were two small, well-defined
clusters at 30 to 50% probability and at greater than 80% probability
of natural infection. The model was able to separate adequately the
vaccinated group from the other two groups having an increased
probability of infection. These samples would have been considered
positive for infection by previously derived criteria. However, the
model determined that only 2.4% were highly likely to be infected and 10.4% were possibly infected.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 2.
Histogram of the probability of natural infection among
vaccinated dogs from areas where Lyme disease is endemic.
|
|
 |
DISCUSSION |
Detection of antibodies corresponding to particular B. burgdorferi antigens, as revealed by immunoblot assay, is useful
in at least two settings. In clinical practice, it is important to determine if a dog that has symptoms resembling Lyme disease and shows
variable antibodies in an immunoblot assay, as a consequence of either
vaccination, natural exposure to B. burgdorferi, or the
presence of heterologous antibodies (20), is actually
infected. In the epidemiologic setting, when dog sera are used in
serosurveys to measure exposure to B. burgdorferi by tick
bite in a given region (16, 18), researchers need to know
whether the antibodies they detect by ELISA or IFA are a consequence of
natural exposure, vaccination, or both. Vaccination confounds the
interpretation of results of serologic and immunoblot assays in both
settings, as no definitive criteria are available for separating
naturally infected from vaccinated dogs. Here, we analyzed canine sera
submitted by veterinary clinics in areas where Lyme disease is endemic
or nonendemic, and where vaccination records were reliably available, in order to determine if such criteria could be derived through statistical analysis.
Previous studies have characterized serological responses in natural
and experimental infections in dogs. Barthold et al. (1)
reported variable immunoblot patterns in natural infections, where the
most frequent reactions were against p41, p39, and p22 (possibly OspC).
Naturally infected dogs have also been found to have strong antibody
responses to p41, p39, and various high-molecular-weight proteins
(14). For naturally exposed dogs, Greene et al.
(10) reported the presence of at least 15 bands on
immunoblots. Major bands included 83 (i.e., 93 by Immunetics immunoblot
assay), 66, 61 to 60, 41 to 39, 31 to 29, 17, and 15 kDa. Samples from
dogs experimentally infected with live spirochetes exhibited the p31 and p34 bands, with usually six or fewer other bands present. Samples
from dogs vaccinated with killed spirochetes also reacted strongly and
predominantly to the p31 and p34 antigens (1, 4).
The logistic regression model showed that vaccinated dogs exhibited
increased frequencies of antibodies to p31 and p34, consistent with
previous studies (1), but also had greater frequencies of
the p28 (possibly OspF, a surface lipoprotein) and p93 bands. The p41
band could not be used to distinguish between the two groups, and it
was also consistently present in immunoblot-negative samples from dogs
that had been vaccinated against leptospirosis. It is important to
emphasize that p23 (OspC) was not found to be a reliable marker
separating vaccinated and naturally infected dogs, even though other
studies have suggested that it should be present in natural infections
(5, 7, 25).
The model showed that among those dogs determined to be naturally
infected, the only bands exhibiting significantly increased frequencies
were p58, p37, p35, and p30. Bands p58 and p30 are considered
significant bands in the human diagnostic criteria for Lyme disease by
the Centers for Disease Control and Prevention (3). p35 and
p37 have been shown to be markers of natural infection in mice by
Fikrig et al. (6). The p39 band has been reported as a
possible marker for natural infection in dogs and mice (1, 10,
29). However, Chu et al. (4) reported that vaccinated dogs had antibodies to p39 in addition to p31 and p34 and Gauthier and
Mansfield (8) found p39 antibodies present in 100% of
naturally infected dogs and in 60% of recently vaccinated dogs. In our
model, p39 antibodies were present in both vaccinated and naturally
infected dogs.
When a vaccinated dog from an area where the disease is endemic is
exhibiting symptoms of Lyme disease and has been previously vaccinated,
it is important to determine if the dog is also harboring an active
infection. The logistic regression model was used to determine if
certain antibodies to B. burgdorferi antigens that are
present in naturally infected dogs were significantly different from
those elicited through vaccination. The model was able to determine
that eight bands were significantly different between the two groups.
Gauthier and Mansfield (8) found specific bands that were
unique to each status; however, in the present study, individual bands
did not seem to be uniquely present in vaccinated or naturally infected
canines. The logistic regression model allows the simultaneous
inclusion and evaluation of the bands for significance and interaction.
An adequate sample size (n = 269) relative to the
number of independent variables (n = 19) ensured
sufficient power to detect the significant differences in bands between
the two groups. The logistic regression equation was derived, and the
presence or absence of significant bands was used to classify the
immunoblot results into the vaccinated or infected status. The model
was then used to compute the probability of a superimposed natural
infection among the vaccinated dogs from areas where the disease is
endemic and predict their serological status.
The bands that were statistically significant in the model were also
found to be biologically significant, as supported by the referenced
literature. However, this model may reflect the band patterns seen in
our study area. Since band patterns may vary regionally, depending on
possible strain variations of B. burgdorferi and different
laboratory protocols, individual laboratories with adequate sample
numbers can develop a model using their own immunoblots to distinguish
between natural infection and the vaccinated state. Using a
quantitative approach for the analysis of immunoblots can aid
veterinarians in the diagnosis of canine Lyme disease and
epidemiologists in a more accurate determination of canine B. burgdorferi prevalence rates, since vaccination has become a
widely accepted method of Lyme disease prevention and its use will
likely continue.
 |
ACKNOWLEDGMENTS |
This study was funded by NIH grant AI36917.
We thank L. Greeley and M. Segre for their assistance with serology and
J. Piesman and R. Weigel for their helpful comments on the preparation
of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Present address: Centers for
Disease Control, Division of Viral and Rickettsial Diseases, Viral and Rickettsial Zoonoses Branch, 1600 Clifton Rd. NE, MS G-13, Atlanta, GA
30333. Phone: (404) 639-1075. Fax: (404) 639-2778.
 |
REFERENCES |
| 1.
|
Barthold, S. W.,
S. A. Levy,
E. Fikrig,
L. K. Bockenstedt, and A. L. Smith.
1995.
Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection.
J. Am. Vet. Med. Assoc.
207:1435-1440[Medline].
|
| 2.
|
Centers for Disease Control and Prevention.
1999.
Methods used for creating a national Lyme disease risk map.
Morb. Mortal. Wkly. Rep.
48(RR07):21-24.
|
| 3.
|
Centers for Disease Control and Prevention.
1995.
Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.
Morb. Mortal. Wkly. Rep.
44:590-591[Medline].
|
| 4.
|
Chu, H. J.,
L. G. Chavez, Jr.,
B. M. Blumer,
R. W. Sebring,
T. L. Wasmoen, and W. M. Acree.
1992.
Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin.
J. Am. Vet. Med. Assoc.
201:403-411[Medline].
|
| 5.
|
Dressler, F.,
J. A. Whalen,
B. N. Reinhardt, and A. C. Steere.
1993.
Western blotting in the serodiagnosis of Lyme disease.
J. Infect. Dis.
167:392-400[Medline].
|
| 6.
|
Fikrig, E.,
S. W. Barthold,
W. Sun,
W. Feng,
S. R. Telford, 3rd, and R. A. Flavell.
1997.
Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity.
Immunity
6:531-539[CrossRef][Medline].
|
| 7.
|
Fung, B. P.,
G. L. McHugh,
J. M. Leong, and A. C. Steere.
1994.
Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.
Infect. Immun.
62:3213-3221[Abstract/Free Full Text].
|
| 8.
|
Gauthier, D. T., and L. S. Mansfield.
1999.
Western immunoblot analysis for distinguishing vaccination and infection status with Borrelia burgdorferi (Lyme disease) in dogs.
J. Vet. Diagn. Investig.
11:259-265[Abstract/Free Full Text].
|
| 9.
|
Greene, R. T.,
R. L. Walker,
E. C. Burgess, and J. F. Levine.
1988.
Heterogeneity in immunoblot patterns obtained by using four strains of Borrelia burgdorferi and sera from naturally exposed dogs.
J. Clin. Microbiol.
26:2287-2291[Abstract/Free Full Text].
|
| 10.
|
Greene, R. T.,
J. F. Levine,
E. B. Breitschwerdt,
R. L. Walker,
H. A. Berkhoff,
J. Cullen, and W. L. Nicholson.
1988.
Clinical and serologic evaluations of induced Borrelia burgdorferi infection in dogs.
Am. J. Vet. Res.
49:752-757[Medline].
|
| 11.
|
Hosmer, D. W., and S. Lemeshow.
1989.
Applied logistic regression.
John Wiley & Sons, Inc., New York, N.Y.
|
| 12.
|
Jacobson, R. H.,
Y. F. Chang, and S. J. Shin.
1996.
Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs.
Semin. Vet. Med. Surg. (Small Anim.)
11:172-182[Medline].
|
| 13.
|
Kleinbaum, D. G.
1994.
Logistic regression: a self-learning text.
Springer-Verlag, New York, N.Y.
|
| 14.
|
Levy, S. A.,
B. A. Lissman, and C. M. Ficke.
1993.
Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas.
J. Am. Vet. Med. Assoc.
202:1834-1838[Medline].
|
| 15.
|
Lindenmayer, J.,
M. Weber,
J. Bryant,
E. Marquez, and A. Onderdonk.
1990.
Comparison of indirect immunofluorescent-antibody assay, enzyme-linked immunosorbent assay, and Western immunoblot for the diagnosis of Lyme disease in dogs.
J. Clin. Microbiol.
28:92-96[Abstract/Free Full Text].
|
| 16.
|
Lindenmayer, J.,
M. Durwood, and A. Onderdonk.
1991.
Dogs as sentinels for Lyme disease in Massachusetts.
Am. J. Public Health
81:1448-1455[Abstract/Free Full Text].
|
| 17.
|
Ma, B.,
D. Christen,
D. Leung, and C. Vigo-Pelfrey.
1992.
Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi.
J. Clin. Microbiol.
30:370-376[Abstract/Free Full Text].
|
| 18.
|
Magnarelli, L.,
J. Anderson,
A. Kaufman,
L. Lieberman, and G. Whitney.
1985.
Borreliosis in dogs from southern Connecticut.
J. Am. Vet. Med. Assoc.
186:955-959[Medline].
|
| 19.
|
Magnarelli, L.,
J. Anderson,
A. Schreier, and C. Ficke.
1987.
Clinical and serological studies of canine borreliosis.
J. Am. Vet. Med. Assoc.
191:1089-1094[Medline].
|
| 20.
|
Magnarelli, L. A.,
J. F. Anderson, and R. C. Johnson.
1987.
Cross-reactivity in serological tests for Lyme disease and other spirochetal infections.
J. Infect. Dis.
156:183-188[Medline].
|
| 21.
|
Magnarelli, L. A.,
R. A. Flavell,
S. J. Padula,
J. F. Anderson, and E. Fikrig.
1997.
Serologic diagnosis of canine and equine borreliosis: use of recombinant antigens in enzyme-linked immunosorbent assays.
J. Clin. Microbiol.
35:169-173[Abstract].
|
| 22.
|
Magnarelli, L. A.,
J. M. Meegan,
J. F. Anderson, and W. A. Chappell.
1984.
Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.
J. Clin. Microbiol.
20:181-184[Abstract/Free Full Text].
|
| 23.
|
Magnarelli, L. A.,
J. N. Miller,
J. F. Anderson, and G. R. Riviere.
1990.
Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease.
J. Clin. Microbiol.
28:1276-1279[Abstract/Free Full Text].
|
| 24.
|
Pachner, A. R., and N. S. Ricalton.
1992.
Western blotting in evaluating Lyme seropositivity and the utility of a gel densitometric approach.
Neurology
42:2185-2192[Abstract/Free Full Text].
|
| 25.
|
Padula, S. J.,
A. Sampieri,
F. Dias,
A. Szczepanski, and R. W. Ryan.
1993.
Molecular characterization and expression of p23 (OspC) from a North American strain of Borrelia burgdorferi.
Infect. Immun.
61:5097-5105[Abstract/Free Full Text].
|
| 26.
|
Schillhorn van Veen, T.,
A. Murphy, and B. Colmeri.
1993.
False positive Borrelia burgdorferi antibody titers associated with periodontal disease in dogs.
Vet. Rec.
132:512[Medline].
|
| 27.
|
Schott, S.
1991.
Logistic regression and discriminant analysis.
J. Am. Vet. Med. Assoc.
198:1902-1903[Medline].
|
| 28.
|
Schwan, T. G.,
J. Piesman,
W. T. Golde,
M. C. Dolan, and P. A. Rosa.
1995.
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
Proc. Natl. Acad. Sci. USA
92:2909-2913[Abstract/Free Full Text].
|
| 29.
|
Simpson, W. J.,
W. Burgdorfer,
M. E. Schrumpf,
R. H. Karstens, and T. G. Schwan.
1991.
Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals.
J. Clin. Microbiol.
29:236-243[Abstract/Free Full Text].
|
| 30.
|
Walker, E. D.,
M. G. Stobierski,
M. L. Poplar,
T. W. Smith,
A. J. Murphy,
P. C. Smith,
S. M. Schmitt,
T. M. Cooley, and C. M. Kramer.
1998.
Geographic distribution of ticks (Acari: Ixodidae) in Michigan, with emphasis on Ixodes scapularis and Borrelia burgdorferi.
J. Med. Entomol.
35:872-882[Medline].
|
| 31.
|
Wittenbrink, M. M.,
K. Failing, and H. Krauss.
1996.
Enzyme-linked immunosorbent assay and immunoblot analysis for detection of antibodies to Borrelia burgdorferi in dogs. The impact of serum absorption with homologous and heterologous bacteriae.
Vet. Microbiol.
48:257-268[CrossRef][Medline].
|
| 32.
|
Zoller, L.,
S. Burkard, and H. Shafer.
1991.
Validity of Western immunoblot patterns in the serodiagnosis of Lyme borreliosis.
J. Clin. Microbiol.
29:174-182[Abstract/Free Full Text].
|
| 33.
|
Zoller, L.,
J. Cremer, and M. Faulde.
1993.
Western blot as a tool in the diagnosis of Lyme borreliosis.
Electrophoresis
14:937-944[CrossRef][Medline].
|
Journal of Clinical Microbiology, July 2000, p. 2628-2632, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gerber, B., Haug, K., Eichenberger, S., Reusch, C. E., Wittenbrink, M. M.
(2009). Comparison of a rapid immunoassay for antibodies to the C6 antigen with conventional tests for antibodies to Borrelia burgdorferi in dogs in Europe. Vet Rec.
165: 594-597
[Abstract]
[Full Text]
-
O'Connor, T. P., Esty, K. J., Hanscom, J. L., Shields, P., Philipp, M. T.
(2004). Dogs Vaccinated with Common Lyme Disease Vaccines Do Not Respond to IR6, the Conserved Immunodominant Region of the VlsE Surface Protein of Borrelia burgdorferi. CVI
11: 458-462
[Abstract]
[Full Text]
-
MAGNARELLI, L. A., LEVY, S. A., IJDO, J. W., WU, C., PADULA, S. J., FIKRIG, E.
(2001). Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis. J Med Microbiol
50: 889-895
[Abstract]
[Full Text]